Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma

Mark A. Henderson, Haider Shirazi, Simon S. Lo, Marc Mendonca, Achilles J. Fakiris, Thomas C. Witt, Robert M. Worth, Robert D. Timmerman

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Uveal melanoma is the most common primary intraocular malignant tumor. Radiation therapy has now replaced enucleation as the treatment of choice, with radioactive eye plaques and proton therapy being the two most studied radiotherapy modalities. More recently, stereotactic radiosurgery and fractionated stereotactic radiotherapy have emerged as promising, non-invasive treatments for uveal melanoma. This review summarizes the available literature on these newer treatment modalities.

Original languageEnglish
Pages (from-to)411-419
Number of pages9
JournalTechnology in Cancer Research and Treatment
Volume5
Issue number4
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Radiosurgery
Radiotherapy
Proton Therapy
Therapeutics
Uveal melanoma
Neoplasms

Keywords

  • Fractionated Stereotactic Radiotherapy
  • Stereotactic Radiosurgery
  • Uveal Melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

Henderson, M. A., Shirazi, H., Lo, S. S., Mendonca, M., Fakiris, A. J., Witt, T. C., ... Timmerman, R. D. (2006). Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma. Technology in Cancer Research and Treatment, 5(4), 411-419.

Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma. / Henderson, Mark A.; Shirazi, Haider; Lo, Simon S.; Mendonca, Marc; Fakiris, Achilles J.; Witt, Thomas C.; Worth, Robert M.; Timmerman, Robert D.

In: Technology in Cancer Research and Treatment, Vol. 5, No. 4, 08.2006, p. 411-419.

Research output: Contribution to journalArticle

Henderson, MA, Shirazi, H, Lo, SS, Mendonca, M, Fakiris, AJ, Witt, TC, Worth, RM & Timmerman, RD 2006, 'Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma', Technology in Cancer Research and Treatment, vol. 5, no. 4, pp. 411-419.
Henderson, Mark A. ; Shirazi, Haider ; Lo, Simon S. ; Mendonca, Marc ; Fakiris, Achilles J. ; Witt, Thomas C. ; Worth, Robert M. ; Timmerman, Robert D. / Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma. In: Technology in Cancer Research and Treatment. 2006 ; Vol. 5, No. 4. pp. 411-419.
@article{ce93468e20f043019edb4b77bde5eb64,
title = "Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma",
abstract = "Uveal melanoma is the most common primary intraocular malignant tumor. Radiation therapy has now replaced enucleation as the treatment of choice, with radioactive eye plaques and proton therapy being the two most studied radiotherapy modalities. More recently, stereotactic radiosurgery and fractionated stereotactic radiotherapy have emerged as promising, non-invasive treatments for uveal melanoma. This review summarizes the available literature on these newer treatment modalities.",
keywords = "Fractionated Stereotactic Radiotherapy, Stereotactic Radiosurgery, Uveal Melanoma",
author = "Henderson, {Mark A.} and Haider Shirazi and Lo, {Simon S.} and Marc Mendonca and Fakiris, {Achilles J.} and Witt, {Thomas C.} and Worth, {Robert M.} and Timmerman, {Robert D.}",
year = "2006",
month = "8",
language = "English",
volume = "5",
pages = "411--419",
journal = "Technology in Cancer Research and Treatment",
issn = "1533-0346",
publisher = "Adenine Press",
number = "4",

}

TY - JOUR

T1 - Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma

AU - Henderson, Mark A.

AU - Shirazi, Haider

AU - Lo, Simon S.

AU - Mendonca, Marc

AU - Fakiris, Achilles J.

AU - Witt, Thomas C.

AU - Worth, Robert M.

AU - Timmerman, Robert D.

PY - 2006/8

Y1 - 2006/8

N2 - Uveal melanoma is the most common primary intraocular malignant tumor. Radiation therapy has now replaced enucleation as the treatment of choice, with radioactive eye plaques and proton therapy being the two most studied radiotherapy modalities. More recently, stereotactic radiosurgery and fractionated stereotactic radiotherapy have emerged as promising, non-invasive treatments for uveal melanoma. This review summarizes the available literature on these newer treatment modalities.

AB - Uveal melanoma is the most common primary intraocular malignant tumor. Radiation therapy has now replaced enucleation as the treatment of choice, with radioactive eye plaques and proton therapy being the two most studied radiotherapy modalities. More recently, stereotactic radiosurgery and fractionated stereotactic radiotherapy have emerged as promising, non-invasive treatments for uveal melanoma. This review summarizes the available literature on these newer treatment modalities.

KW - Fractionated Stereotactic Radiotherapy

KW - Stereotactic Radiosurgery

KW - Uveal Melanoma

UR - http://www.scopus.com/inward/record.url?scp=33748084399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748084399&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 411

EP - 419

JO - Technology in Cancer Research and Treatment

JF - Technology in Cancer Research and Treatment

SN - 1533-0346

IS - 4

ER -